University of North Carolina at Chapel Hill
Dr. Bataller’s current research focuses on alcoholic liver disease. He performs translational research that includes clinical studies, translational studies in human samples and experimental models, as well as some epidemiological studies. From the clinical point of view, his team is studying the factors that influence long-term survival in patients with alcoholic hepatitis. They are also leading an international study (CLASH) to provide a new nomenclature and a clinical, analytical, histological and molecular characterization of early forms of steatohepatitis.
Dr. Bataller’s team is performing translational studies in human samples form patients with alcoholic hepatitis to develop a molecular classification for targeted therapies. Moreover, they are performing experimental studies in animal and cell models to study the role of several molecular targets (i.e. KRT23, NGAL) in alcoholic injury, and epidemiological studies to uncover the main determinants of the burden of alcoholic cirrhosis globally.